Triple therapy regime puts patients with leukemic form of cutaneous lymphoma in remission

A three-pronged immunotherapy approach nearly doubles five-year survival among patients with rare leukemic form of cutaneous T-cell lymphoma, reports a new study by dermatologists from the Abramson Cancer Center and Perelman School of Medicine at the University of Pennsylvania.

Read the whole article on Physorg

More from Physorg